The present invention relates to an siRNA targeting PRK2, which is a hepatitis C virus therapeutic agent, and can be effectively used as a hepatitis C virus therapeutic agent since the systemic delivery into a living body, particularly liver cells, is possible through an siRNA targeting a host PRK2 gene, which shows an anti-HCV activity, or a lipid formulation thereof.
무선 통신 시스템에서 낮은 지연을 위한 신호 송수신 방법 및 이를 위한 장치patents-wipo patents-wipo